Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease

Biomarkers of brain Aβ amyloid deposition can be measured either by cerebrospinal fluid Aβ42 or Pittsburgh compound B positron emission tomography imaging. Our objective was to evaluate the ability of Aβ load and neurodegenerative atrophy on magnetic resonance imaging to predict shorter time-to-prog...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jack, Clifford R., Wiste, Heather J., Vemuri, Prashanthi, Weigand, Stephen D., Senjem, Matthew L., Zeng, Guang, Bernstein, Matt A., Gunter, Jeffrey L., Pankratz, Vernon S., Aisen, Paul S., Weiner, Michael W., Petersen, Ronald C., Shaw, Leslie M., Trojanowski, John Q., Knopman, David S.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2010
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2965425/
https://ncbi.nlm.nih.gov/pubmed/20935035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awq277
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars